Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box)

Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) belongs to the drug class of monoclonal antibodies. It works by targeting a specific protein called human epidermal growth factor receptor 2 (HER2) that is found in some types of cancer cells. This medication is used in the treatment of certain types of breast cancer and gastric cancer. It is important to note that Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) may cause side effects such as nausea, diarrhea, fatigue, and alopecia. Patients should be aware of common counseling points, such as the need for regular monitoring during treatment and the importance of discussing any new symptoms or concerns with their healthcare provider.

Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) is indicated for the treatment of HER2-positive breast cancer, which is a type of breast cancer that has an overexpression of the HER2 protein. It is also indicated for the treatment of HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. The mode of action of Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) involves binding to the HER2 protein, thereby inhibiting its function and slowing down the growth of cancer cells.

Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) should be administered by a healthcare professional through a vein. The recommended dose and duration of treatment may vary depending on the specific indication. It is important to follow the instructions provided by the healthcare provider and to not miss any scheduled doses.

The recommended dosage of Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) is 6 mg per kilogram of body weight, administered over a period of 90 minutes. The infusion should be repeated every three weeks until disease progression or unacceptable toxicity occurs.

The shelf life for Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) for Concentrate for Solution for Infusion is typically around 24 months when stored properly according to the manufacturer's recommendations.

Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) should be stored in a refrigerator at a temperature between 2°C and 8°C (36°F and 46°F). It should be protected from light and should not be frozen. Once the powder is reconstituted and diluted, it should be used immediately or stored in a refrigerator and used within 24 hours.

• Nausea
• Diarrhea
• Fatigue
• Alopecia (hair loss)
• Neutropenia (low white blood cell count)
• Infection
• Fever
• Anemia
• Rash
• Infusion-related reactions (such as fever, chills, and flushing)
• Cardiotoxicity (heart problems)
• Pulmonary toxicity (lung problems)

Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) is contraindicated in patients who are hypersensitive to trastuzumab or any of the excipients of the product. It should not be used in patients with a known severe hypersensitivity reaction to trastuzumab.

There are no known drug interactions that have been reported for Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box). However, it is important to inform the healthcare provider about all medications, including over-the-counter drugs and herbal supplements, being taken prior to starting treatment with Herzuma.

• Follow the instructions provided by the healthcare provider for the proper administration of Herzuma.
• Report any new or worsening symptoms to the healthcare provider promptly.
• Attend all scheduled appointments for monitoring during treatment.
• Store Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) in the refrigerator, protected from light, and do not freeze it.
• Do not use Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) if it has expired.
• Inform the healthcare provider about all medications being taken, including over-the-counter drugs and herbal supplements.

1. Can Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) cause hair loss as a side effect?
   Hair loss is not a common side effect of Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box), but it is important to discuss any concerns with your healthcare provider.

2. How long does a typical infusion of Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box) take?
   The duration of an infusion can vary, but generally takes around 30 minutes to complete.

3. Are there specific dietary restrictions while taking Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box)?
   There are no specific dietary restrictions associated with Herzuma 440 mg Powder for Concentrate for Solution for Infusion 1 Vial (Box), but it is important to follow a healthy and balanced diet during treatment.